Anatomical, pharmacological and human post-mortem studies suggest the dopamine D 3 receptor (DRD3) gene as a candidate for drug dependence. We thus performed an association study of the Bal I polymorphism at the DRD3 gene, including 54 opiate addicts and 70 controls. Opiate addicts had a higher sensation-seeking score (on the Zü ckerman scale) than controls (P = 0.001), particularly a subgroup (70%) who had a distinctly higher score, exceeding 24. There were no marked differences in genotypes between patients as a whole and controls. However, patients with a sensation-seeking score above 24 were more frequently homozygotes for both alleles than patients with a sensation-seeking score under 24 (P = 0.038) or controls (P = 0.034). Although obtained in a sample of limited size, these results suggest that the DRD3 gene may have a role in drug dependence susceptibility in individuals with high sensation-seeking scores. This hypothesis is consistent with the role of DRD3 in mediating responses to drugs of abuse in animals and the association of homozygosity at the Bal I polymorphism with drug abuse in schizophrenic patients (see companion article by Krebs et al).
expression. 9 Furthermore, DRD3 binding 10 and gene transcripts 11 are elevated in the ventral striatum of cocaine fatalities. These experimental and clinical observations suggest the DRD3 gene as a candidate for susceptibility to drug dependence.
We recruited 54 patients with opiate dependence and without schizophrenia, both according to DSM-III-R criteria (mean age ± s.d. 32.3 ± 6.1 yrs), and 70 controls without drug use or any psychiatric disease (mean age 42.2 ± 7 yrs), all white males of French ancestry. The older age of controls minimises the risk of including not yet revealed addicts. Twenty-nine patients had less than three life-time comorbid substance dependences, and 25 more than three comorbid dependences. The age of first opiate use was 18.6 ± 2.9 yrs.
The sensation-seeking score, as assessed using the Zü ckerman scale, was significantly higher in patients (26 ± 5) than in controls (17 ± 6, P = 0.001). The sensation-seeking score in patients was found inversely correlated with age (r = −0.37, P = 0.005), as it is in the general population. 12 However, testing for normality the distribution of patients according to their sensation-seeking scores led to a non-significant value (P = 0.10). In fact, there is a trend toward a bimodal distribution of patients, of whom a particular fraction had distinctly higher scores (Ͼ24) than other patients and controls (Figure 1 ). Patients with a sensation-seeking score above 24 (n = 38) were more frequently cocaine addicts (n = 19 vs n = 2, 2 = 6.66, d.f. = 1, P = 0.0098) or amphetamine addicts (n = 12 vs n = 1, 2 = 3.95, d.f. = 1, P = 0.047) than patients with a score under 24 (n = 16). Patients were also more impulsive than controls (Barrat's score of 70 ± 19 vs 43 ± 15, P = 0.001).
All samples were genotyped for the Bal I polymorphism at the DRD3 gene by investigators blind to the clinical status of the donor, using PCR with primers identical to those originally described. 13 In addition, the genotypes were confirmed in 13 samples using nested primers to amplify a shorter part of the same sequence. Furthermore, we established by amplification of various mixtures of DNAs from controls and patients, that the presence of either allele did not interfere with the detection of the other one (not shown). There was no significant difference in allelic frequency in patients and controls ( 2 = 0.98, d.f. = 1, P = 0.16, Table 1 ). Genotype distribution in our control sample was in accordance with the Hardy-Weinberg equilibrium ( 2 = 0.34, d.f. = 1, P = 0.56) and was similar to that in a large control sample of 1013 subjects. 14 The genotype distribution in patients differed significantly from the Hardy-Weinberg equilibrium ( 2 = 3.91, d.f. = 1, P = 0.048), but was not significantly different from the genotype distribution in controls ( 2 = 4.18, d.f. = 2, P = 0.12). However, patients with a sensation-seeking score above 24 had a genotype distribution significantly different from that in controls ( 2 = 7.00, d.f. = 2, P = 0.03). They were more frequently homozygotes for both alleles than patients with a sensation-seeking score under 24 ( Table 1 ). A two-way ANOVA showed that there is still a significant difference in genotype distributions between patients with high or low sensation-seeking scores after adjusting for age at interview (F 1,50 = 4.5, P = 0.039), and that there is no significant interaction between age and genotype distribution (F 1,50 = 0.02, P = 0.90).
Although limited, a similar excess of homozygotes at DRD3 Bal I polymorphism was found in white, but not black American cocaine addicts. 15 The positive results obtained in these two independent samples suggest a role of DRD3 gene in the susceptibility to drug dependence. There was a deviation from the Hardy-Weinberg equilibrium in patients with a sensation-seeking score above 24 ( 2 = 8.16, 1 d.f., P = 0.004), due to an over-representation of homozygotes, but not in patients with a sensation-seeking score under 24 ( 2 = 0.50, 1 d.f., P = 0.48). One explanation for the apparent excess of homozygotes among patients, could be a deletion of the DRD3 gene in the region amplified by PCR during genotyping. In this hypothesis, these patients would have one null allele, leading to a loss of DRD3 and consequently a defect of their rewarding system, in agreement with the role of this receptor in rewarding effects of abused drugs. [5] [6] [7] [8] On the other hand, it cannot be excluded that the presence of two identical proteins could alter in some unknown manner the processing or the function of the receptor. Another example of overrepresentation of homozygotes for either allele has been found at the polymorphic codon 129 in the protein of patients with sporadic CreutzfeldtJakob disease. 16 Substance addicts have higher sensation-seeking scores, which can be regarded as a vulnerability factor to drug use in the general population. 17 An equivalent in rodents of sensation seeking in humans could be the increased exploratory locomotion in a novel environment, shown to be associated with high craving for psychostimulants in rats. 18 Interestingly, a specific role of DRD3 in exploratory locomotion was established by the use of DRD3 knock-out mice 19 and DRD3 selective antagonists. 20, 21 It appears that drug addicts favoring amphetamine, a dopamine indirect agonist, tend to have higher sensation-seeking scores. 22, 23 Our subpopulation of opiate addicts with higher sensation-seeking scores display more often comorbid life-time dependence to amphetamine or/and cocaine, another dopamine indirect agonist. In addition, administration of levodopa, another dopamine indirect agonist, to parkinsonians who have been unresponsive to their environment since they were young adults, resulted in a dramatic awakening, including increased interest in the environment and other signs of sensation seeking. 24 Furthermore, an association was found in the general population between dopamine D4 receptor and the human personality trait of novelty seeking. 25 Opiates, as well as cocaine and amphetamine, stimulate the same mesolimbic dopaminergic system. Thus, both animal and clinical studies suggest reward-controlling dopamine systems as biological substrates primarily involved in sensation seeking, which is consistent with the association found in the present study between DRD3 and sensation seeking.
No association has been found between DRD3 gene and alcohol dependence in alcohol-only users, who have lower sensation-seeking scores than alcoholics also using other drugs. [26] [27] [28] Alcohol-only users thus resemble opiate addicts with low sensation-seeking scores, who did not differ from controls with respect to DRD3 genotypes. On the other hand, association between DRD3 and schizophrenia has also been reported, but there is a much higher proportion of drug addicts among schizophrenic patients (35-40%) than in the general population. 29 Drug abuse or dependence in schizophrenic patients can precede the start of neuroleptic medication, 30 and thus appears linked to the disease rather than to the treatment. In addition, the DRD3 gene was associated in one study with schizophrenia when taking into account only those patients having life-time drug abuse or dependence. 31 In conclusion, DRD3 gene homozygosity is associated in our population with opiate dependence in patients with high sensation-seeking scores. This finding needs to be confirmed in a larger sample or in replicating studies.
Methods

Subject recruitment
All subjects included in the study were white males of French ancestry and gave their written informed consent. Both controls and opiate addicts were evaluated using the Diagnostic Interview of Genetic Studies (DIGS) with DSM-III-R criteria. The sample of 70 controls was composed of blood platelet donors, recruited at Hô pital Beaujon in Clichy (France), without life-time psychiatric personal disease. The sample of opiate addicts included 54 subjects, outpatients at the Dispensaire Moreau de Tours in Hô pital Sainte-Anne in Paris (France), with life-time DSM-III-R criteria of opiate dependence, excluding schizophrenics. Twenty-four patients included were on methadone maintenance therapy. A family history of drug or alcohol abuse was recorded during the face to face proband's interview (DIGS) in 36 out of 54 patients.
Sensation seeking and impulsiveness evaluation
Both controls and patients were assessed with the Zuckerman's sensation-seeking scale 12 and Barrat's impulsiveness scale. 32 The Zuckerman sensation-seeking scale is built from a 40-items self-questionnaire, and evaluates disinhibition, danger seeking, experience seeking, and boredom susceptibility. The Barrat's impulsiveness scale is built from a 34-items self-questionnaire and evaluates motor impulsivity, cognitive impulsivity and non-planning.
DNA extraction and analysis
Whole blood collected in EDTA-coated tubes was stored at −20°C, and DNA was extracted from leukocytes. The PCR reaction was carried out as described 13 with the following primers: 5Ј-GCT CTA TCT CCA ACT CTC ACA-3Ј, situated before the first ATG of the D3 receptor gene and 5Ј-AAG TCT ACT CAC CTC CAG GTA-3Ј, located in intron 1. In some experiments, amplification was carried out with nested primers 5Ј-TTT ATC TGT TTT GTT CAT TGC-3Ј and 5Ј-CAT AGA GTC AAC ATG CAC CTG-3Ј.
Statistical analysis
Comparison between quantitative variables was carried out with the Mann-Whitney non-parametric test. Links between qualitative variables were calculated with 2 test or Fisher exact test when necessary. In order to test the interaction between age at interview and genotype distribution on sensation-seeking scores, a two-way ANOVA was performed on patients separated into two classes under and over 32 yrs.
